Assembly and Dynamics of Molecular Machines in Genome Maintenance
Project Number2R35GM131704-06
Former Number3R35GM131704-05S1
Contact PI/Project LeaderSPIES, MARIA
Awardee OrganizationUNIVERSITY OF IOWA
Description
Abstract Text
ABSTRACT
Efficient genome maintenance is a double-edged sword. Accurate repair of DNA lesions and damaged
replication forks promotes genome stability, which is a key to avoiding cancer, aging and neurodegenerative
diseases associated with DNA repeat expansion. The same mechanisms that maintain genome integrity in
healthy cells, allow cancer cells to acquire a more aggressive character and develop resistance to radiation and
chemotherapy. Untimely deployment and/or dysregulation of the DNA repair machines may further destabilize
the genome or may result in the accumulation of geno- and cytotoxic repair intermediates. Significant gaps
remain in our understanding of the molecular events that funnel the intermediates of otherwise accurate repair
into “rogue”, genome-destabilizing mechanisms.
This research program emphasizes the molecular and structural mechanisms by which the intermediates of DNA
metabolism bound by Replication Protein A (RPA) are channeled into DNA repair, protection of DNA replication
forks, homologous recombination, DNA damage tolerance and signaling.
Our central hypothesis is that the activities of the RAD51 recombinase, the ssDNA-binding protein RPA,
recombination mediators BRCA2 (in human) and Rad52 (in yeast), and DNA repair helicases are finely tuned by
a variety of factors, which include posttranslational modifications, interacting partner proteins, specific DNA
structures and DNA lesions. These factors affect the protein configurational dynamics and critical protein-protein
interfaces. Understanding how the protein plasticity and kinetics of assembly of the macromolecular machines
of DNA repair will show us new ways to selectively manipulate the activities of RAD51, RPA and multifunctional
DNA helicases and polymerases in DNA replication and repair.
We are leveraging and building the tools of single-molecule biochemistry, biophysics, structural and chemical
biology. Our unique perspective on the formation, activities and regulation of the nucleoprotein complexes
orchestrating genome maintenance is rooted in our ability to visualize microscopic configurational dynamics of
and sort individual human DNA repair proteins with their native posttranslational modifications, and to probe and
separate activities associated with different surface-tethered proteins and nucleoprotein complexes at the single-
molecule level. Our goal is to provide an entirely new outlook on how the cell balances the assembly and activities
of the molecular machines that can repair, but also destabilize, the genome, and to be able to alter this balance
with new chemotherapeutics targeting cancer and neurodegenerative diseases.
Public Health Relevance Statement
PROJECT NARRATIVE
Molecular machines that function in DNA repair maintain integrity of the genome by promoting faithful repair of
the most genotoxic DNA lesions and faithful genome replication. Defects in their regulation can lead to genetic
instability and chromosomal rearrangements causing cancer, aging, and diseases associated with progressive
expansion of repeated sequences (including Huntington's disease, myotonic dystrophy and Fragile X
syndrome). Understanding the fundamental molecular mechanisms of how DNA repair is regulated and its
dysregulation will reveal features, which can be exploited in developing novel therapeutics.
No Sub Projects information available for 2R35GM131704-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R35GM131704-06
Patents
No Patents information available for 2R35GM131704-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R35GM131704-06
Clinical Studies
No Clinical Studies information available for 2R35GM131704-06
News and More
Related News Releases
No news release information available for 2R35GM131704-06
History
No Historical information available for 2R35GM131704-06
Similar Projects
No Similar Projects information available for 2R35GM131704-06